Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | N/A | 0 | 0 | 658 |
| TOTAL | $0 | $N/A | $0 | $0 | $658 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 29 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $29 |
| Total Assets | $0 | $N/A | $0 | $0 | $679 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 267 |
| Accrued Expenses | 0 | N/A | 0 | 0 | 360 |
| TOTAL | $0 | $N/A | $0 | $0 | $4,627 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $0 | $N/A | $0 | $0 | $4,627 |
| Shareholders' Equity | |||||
| Common Shares | 0 | N/A | 0 | 0 | 1 |
| Retained earnings | 0 | N/A | 0 | 0 | -7,955 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 3,996 |
| TOTAL | $0 | $N/A | $0 | $0 | $-3,948 |
| Total Liabilities And Equity | $0 | $0 | $0 | $0 | $679 |